Navigation Links
Carrington Reports Third Quarter 2007 Results
Date:11/27/2007

Turner stated, "We continue to focus our strategy on building the clinical foundation of the GelSite(R) polymer drug delivery and adjuvant technologies and on moving them toward commercial introduction. We are seeing increasing interest from both commercial companies and government health agencies in our vaccine and therapeutic delivery systems for both nasal and injectible formulations. In addition, we continue on the path toward filing an IND and conducting a Phase I clinical study in early 2008 of the GelVac(TM) nasal powder influenza H5N1 (bird flu) vaccine."

Conference Call Scheduled

Investors are invited to listen to the conference call scheduled on Tuesday, November 27, 2007, at 4.30 p.m. Eastern, 3.30 p.m. Central, by dialing 1-866-825-3209 in the US or 617-213-8061 internationally. The pass code is 13738306. The call is also being web cast by CCBN and can be accessed at Carrington's website at http://www.carringtonlabs.com. A replay of the call will be available a few hours after the call concludes by dialing 1-888-286-8010 in the US and 617-801-6888 internationally. The pass code for the replay is 83847473.

The web cast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors may listen to the call at http://www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors may access the call via Thomson's password-protected event management site, StreetEvents (http://www.streetevents.com).

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mu
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. Carrington Reports Second Quarter 2007 Results
3. Carrington Completes $8 Million Financing
4. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
7. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
8. Carrington Reports on ISO 9001:2000 Inspection
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... October 30, 2014 On October ... Medicine Showcase in Chicago, leading applied stem cell ... Dr. Wade McKenna presented talks on New Techniques ... Surgical Applications For Stem Cells. , Dr. Riordan ... and the properties of AlphaGEMS that include: wound ...
(Date:10/30/2014)... 2014 James Sherley says he has been ... stem cell technology since his days as a principal investigator ... the late 1990’s. Sherley founded the ASCTC as a ... all the intellectual property developed in Sherley’s research over the ... Institute of Technology (MIT), and more recently as a senior ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success and the ... fleet of high volume High Pressure Processing (HPP) systems. , ... to PackExpo this year, which is where we first announced ... Williams, CEO at Avure. “Sales of the new Avure machine ... the challenges of market demand for higher throughput. We sold ...
(Date:10/30/2014)... A new report, commissioned by BioCrossroads and conducted by ... at Indiana,s capital market and ... time frames: 1993 to 2002 and 2003 to 2013.  ... investment growth.  The Life Science Innovation Capital in ... innovation dollars as well as an increase in life ...
Breaking Biology Technology:Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 2Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 3Riordan-McKenna Institute Founders, Neil Riordan, PhD and Orthopedic Surgeon, Dr. Wade McKenna Present at the Mid American Regenerative and Cellular Medicine Showcase 4Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 2New report shows Indiana's gains in life sciences innovation capital outpace the nation 3New report shows Indiana's gains in life sciences innovation capital outpace the nation 4New report shows Indiana's gains in life sciences innovation capital outpace the nation 5
... , ... FibraCel disks are a new cell-growth matrix that ... when used in spinners, disposable bottles and bags. New Brunswick,Scientific offers ... FibraStage , a simple,and disposable culture system that outperforms spinners, ...
... , , ... , , ... the,production of a product by means of the mass culture of a ... either be: 1. The cell itself: referred to as biomass production., ...
... , ... , New Brunswick ... virus or,cell mass from anchorage-dependent or suspension cultures.,More productive than traditional roller ... simple to operate, and disposable. Typical,yields of 4.9 x 10 9 ...
Cached Biology Technology:A technique for increasing yields in bioreactors and disposable cell-culture systems 2A technique for increasing yields in bioreactors and disposable cell-culture systems 3A technique for increasing yields in bioreactors and disposable cell-culture systems 4FERMENTATION BASICS 2FERMENTATION BASICS 3FERMENTATION BASICS 4FERMENTATION BASICS 5FERMENTATION BASICS 6FERMENTATION BASICS 7FERMENTATION BASICS 8FERMENTATION BASICS 9FERMENTATION BASICS 10FERMENTATION BASICS 11FERMENTATION BASICS 12FERMENTATION BASICS 13FERMENTATION BASICS 14FERMENTATION BASICS 15FERMENTATION BASICS 16Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 2Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 3Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 4Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 5Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 6Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 7Inoculation, Growth & Harvesting in a New Easy-to-Use Disposable Cell Culture System 8
(Date:10/29/2014)... from household and industrial products are in the environment ... most of them, scientists have yet to determine whether ... step toward doing that by estimating which substances people ... published in the ACS journal Environmental Science & ... that the risks to human health of any given ...
(Date:10/29/2014)... kind of stem cell, those referred to as ,facultative, ... is apparently nothing that differentiates these cells from the ... they retain the capacity to become stem cells again. ... an organ that hosts cells that stimulate tissue growth, ... case of a transplant. Knowledge of the underlying ...
(Date:10/29/2014)... the international Cancer Genomics of the Kidney consortium ... kidney cancer and exposure to aristolochic acid, an ... in Nature Communications , have important implications ... than 140,000 people every year, and in Central ... part of the International Cancer Genome Consortium (ICGC), ...
Breaking Biology News(10 mins):A mechanism that allows a differentiated cell to reactivate as a stem cell revealed 2Kidney cancer in Central Europe 2
... that some type of protective system goes into action ... deficient. This discovery indicates a hidden safety net that ... immune system such as AIDS. The Mayo Clinic-led study ... is reported in the early online edition of the ...
... for the first time. An international team led by ... Science published an analysis of the marsupial genome in the ... of an important cluster of immune genes known as the ... (Monodelphis domestica), a marsupial found in South America. , ...
... antibacterial coatings on hip and knee implants and biomedical ... surgery and significantly reduce health care costs and improve ... of South Australia have found. , A significant number ... after surgery and in many cases are not amenable ...
Cached Biology News:Infant transplant patients resist infections that kill adult AIDS patients 2Infant transplant patients resist infections that kill adult AIDS patients 3Marsupial genome reveals insights into mammalian evolution 2Antibacterial coatings cut infection rates 2Antibacterial coatings cut infection rates 3
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Rabbit polyclonal antibody to GluR2...
...
... contains sufficient materials for 1,464 array sample elements. , ... each , Blocker BSA in PBS (10X): 50 ... , BupH Phosphate Buffered Saline: 8 packs , ... West Pico Luminol Enhancer: 2 x 25 ml , ...
Biology Products: